Jove
Visualize
联系我们

相关概念视频

Diseases of the Liver and Gallbladder01:26

Diseases of the Liver and Gallbladder

614
Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
614
Hepatic Portal System01:21

Hepatic Portal System

1.5K
The hepatic portal system, a critical part of our circulatory framework, transports nutrient-laden, deoxygenated blood from the gastrointestinal tract and spleen to the liver. This ingenious system plays an indispensable role in maintaining our body's metabolic equilibrium.
At its core, the hepatic portal vein is the result of a confluence of the superior and inferior mesenteric veins along with the splenic vein. Each of these veins has a unique role. The superior mesenteric vein is...
1.5K
Retrovirus Life Cycles01:10

Retrovirus Life Cycles

46.1K
Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the...
46.1K
Esophageal Varices-II: Clinical Features and Management01:28

Esophageal Varices-II: Clinical Features and Management

86
Esophageal varices often manifest as gastrointestinal bleeding episodes, presenting symptoms like hematemesis (vomiting of blood), hematochezia (passing fresh blood via the rectum), and melena (black, tarry stools). Other signs can include weight loss, anorexia, abdominal discomfort, jaundice, pruritus, altered mental status, and muscle cramps.
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
86

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Large Language Models Accurately Identify People Who Inject Drugs From Infectious Diseases Discharge Summaries in an Australian Hospital.

Drug and alcohol review·2026
Same author

Corrigendum to: Factors associated with delayed diagnosis of hepatitis B in southeastern Sydney.

Public health research & practice·2026
Same author

Mirtazapine for Methamphetamine Use Disorder: A Randomized Clinical Trial.

JAMA psychiatry·2026
Same author

Reinfection following direct-acting antiviral therapy for hepatitis C infection among people in prison with recent injecting drug use: the SHARP-P study.

The International journal on drug policy·2026
Same author

New-onset diabetes following SARS-CoV-2 infection in the Omicron era: a matched cohort study.

International journal of epidemiology·2026
Same author

Interventions to improve testing, linkage to care, and treatment for hepatitis C infection in prison: a systematic review and meta-analysis.

The International journal on drug policy·2026
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关实验视频

Updated: Jul 15, 2025

A Protocol for Analyzing Hepatitis C Virus Replication
13:04

A Protocol for Analyzing Hepatitis C Virus Replication

Published on: June 26, 2014

24.2K

甲型肝炎

Marianne Martinello1, Sunil S Solomon2, Norah A Terrault3

  • 1Viral Hepatitis Clinical Research Program, Kirby Institute, UNSW Sydney, Sydney, NSW, Australia; Department of Infectious Diseases, Prince of Wales Hospital, Sydney, NSW, Australia.

Lancet (London, England)
|September 23, 2023
PubMed
概括
此摘要是机器生成的。

消除C型肝炎病毒 (HCV) 需要改善查,治疗和预防. 直接作用的抗病毒药物提供了希望,但更广泛的公共卫生策略对于到2030年全球消除HCV至关重要.

更多相关视频

A Cell Culture Model for Producing High Titer Hepatitis E Virus Stocks
10:28

A Cell Culture Model for Producing High Titer Hepatitis E Virus Stocks

Published on: June 26, 2020

9.8K
Lipid Droplet Isolation for Quantitative Mass Spectrometry Analysis
10:23

Lipid Droplet Isolation for Quantitative Mass Spectrometry Analysis

Published on: April 17, 2017

10.2K

相关实验视频

Last Updated: Jul 15, 2025

A Protocol for Analyzing Hepatitis C Virus Replication
13:04

A Protocol for Analyzing Hepatitis C Virus Replication

Published on: June 26, 2014

24.2K
A Cell Culture Model for Producing High Titer Hepatitis E Virus Stocks
10:28

A Cell Culture Model for Producing High Titer Hepatitis E Virus Stocks

Published on: June 26, 2020

9.8K
Lipid Droplet Isolation for Quantitative Mass Spectrometry Analysis
10:23

Lipid Droplet Isolation for Quantitative Mass Spectrometry Analysis

Published on: April 17, 2017

10.2K

科学领域:

  • 病毒学
  • 肝病学
  • 公共卫生

背景情况:

  • 肝炎C病毒 (HCV) 导致肝损伤,肝硬化和癌症.
  • 全球消除HCV是世卫组织的目标.
  • 仍有数百万人受到感染, 每年死亡人数显著.

研究的目的:

  • 审查全球HCV感染的现状.
  • 突出直接作用抗病毒疗法 (DAA) 的影响.
  • 确定消除HCV所需的关键策略

主要方法:

  • 对HCV流行和死亡率的流行病学数据的审查.
  • 直接作用抗病毒疗法的临床影响评估.
  • 对HCV控制的公共卫生干预措施的分析.

主要成果:

  • 直接作用的抗病毒药物改变了HCV治疗.
  • 尽管有进展,但全球的HCV负担仍然很大.
  • 在查,与护理联系和治疗覆盖方面存在重大差距.

结论:

  • 实现HCV消除需要多方面的方法.
  • 加强查,关联护理和预防至关重要.
  • 为了实现2030年的消除目标,需要持续努力.